Preclinical activity of LM-305 targeting G-protein-coupled receptor class 5 member D (GPRC5D) antibody drug conjugate for the treatment of multiple myeloma

被引：0
|
作者：
Huang, Wentao [1 ]
Luo, Jie [1 ]
Li, Yifan [1 ]
Fei, Da [1 ]
Qin, Xia [1 ]
Li, Runsheng [1 ]
机构：
[1] LaNova Med, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 44 条
  • [1] A therapeutic antibody against G-protein-coupled receptor class 5 member D to treat multiple myeloma
    He, Feng
    Wu, Kefei
    Liang, Jiabei
    Li, Jianhui
    Peng, Hao
    Wu, Guojin
    Ning, Jinying
    CANCER RESEARCH, 2022, 82 (12)
  • [2] CAR T Cell Therapy Targeting G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D), a Novel Target for the Immunotherapy of Multiple Myeloma
    Smith, Eric L.
    Harrington, Kimberly
    Staehr, Mette
    Masakayan, Reed
    Jones, Jon
    Long, Thomas
    Ghoddusi, Majid
    Purdon, Terence J.
    Do, Trevor
    Wang, Xiuyan
    Minh Pham
    Brown, Jessica M.
    Peguero, Elizabeth
    De Larrea, Carlos Fernandez
    Wang, Pei
    Liu, Hong
    Xu, Yiyang
    Garrett, Sarah
    Almo, Steven
    Riviere, Isabelle
    Liu, Cheng
    Sather, Blythe Duke
    Brentjens, Renier J.
    BLOOD, 2018, 132
  • [3] LEVELS AND PATTERNS OF ORPHAN-G-PROTEIN-COUPLED RECEPTOR, CLASS-C GROUP-5 MEMBER-D (GPRC5D) EXPRESSION IN NORMAL AND ABNORMAL PLASMA CELLS IN INDIAN MULTIPLE MYELOMA PATIENTS
    Jain, Disha
    Ghogale, Sitaram
    Deshpande, Nilesh
    Patil, Jagruti
    Girase, Karishma
    Chatterjee, Gaurav
    Rajpal, Sweta
    Patkar, Nikhil V.
    Bagal, Bhausaheb
    Jain, Hasmukh
    Sengar, Manju
    Hasan, Syed Khizer
    Khattry, Navin
    Subramanian, Papgudi G.
    Gujral, Sumeet
    Tembhare, Prashant R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 48 - 48
  • [4] Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma
    Shaver, Jacob
    Horton, Daniel
    Halford, Zachery
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (04) : 350 - 363
  • [5] A novel T cell engager targeting BCMA and GPRC5D showed promising preclinical activity with low toxic risk for multiple myeloma treatment
    Fu, Yayuan
    You, Shumei
    Wei, Menghao
    Yin, Bowei
    Deng, Qi
    Qin, Xiaokang
    Zhang, Yun
    Wang, Yanqiu
    Tang, Renhong
    CANCER RESEARCH, 2023, 83 (07)
  • [6] A T-cell-redirecting bispecific G-protein-coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
    Pillarisetti, Kodandaram
    Edavettal, Suzanne
    Mendona, Mark
    Li, Yingzhe
    Tornetta, Mark
    Babich, Alexander
    Majewski, Nate
    Husovsky, Matt
    Reeves, Dara
    Walsh, Eileen
    Chin, Diana
    Luistro, Leopoldo
    Joseph, Jocelin
    Chu, Gerald
    Packman, Kathryn
    Shetty, Shoba
    Elsayed, Yusri
    Attar, Ricardo
    Gaudet, Francois
    BLOOD, 2020, 135 (15) : 1232 - 1243
  • [7] Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
    Jurgens, Eric M.
    Firestone, Ross S.
    Chaudhari, Jagrutiben
    Hosszu, Kinga
    Devlin, Sean M.
    Shah, Urvi A.
    Landa, Jonathan
    Mcavoy, Devin P.
    Lesokhin, Alexander M.
    Korde, Neha
    Hassoun, Hani
    Tan, Carlyn R.
    Hultcrantz, Malin
    Shah, Gunjan L.
    Landau, Heather J.
    Chung, David J.
    Scordo, Michael
    Eren, Ozgur Can
    Dogan, Ahmet
    Giralt, Sergio A.
    Park, Jae H.
    Riviere, Isabelle
    Brentjens, Renier J.
    Smith, Eric L.
    Wang, Xiuyan
    Usmani, Saad Z.
    Mailankody, Sham
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [8] Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma
    Mailankody, Sham
    Diamonte, Claudia
    Fitzgerald, Lisa
    Kane, Peter
    Wang, Xiuyan
    Sikder, Devanjan S.
    Senechal, Brigitte
    Bermudez, Vladimir P.
    Frias, Diana
    Morgan, Justina
    Grant, Patrick
    Purdon, Terence J.
    Hosszu, Kinga
    Devlin, Sean M.
    Shah, Urvi A.
    Landa, Jonathan
    Lesokhin, Alexander
    Korde, Neha
    Hassoun, Hani
    Tan, Carlyn
    Hultcrantz, Malin
    Shah, Gunjan L.
    Landau, Heather J.
    Chung, David J.
    Scordo, Michael
    Roshal, Mikhail
    Landgren, Ola
    Dogan, Ahmet
    Giralt, Sergio A.
    Park, Jae H.
    Riviere, Isabelle
    Brentjens, Renier J.
    Smith, Eric L.
    BLOOD, 2021, 138
  • [9] Cloning and characterization of a human orphan family C G-protein coupled receptor GPRC5D
    Bräuner-Osborne, H
    Jensen, AA
    Sheppard, PO
    Brodin, B
    Krogsgaard-Larsen, P
    O'Hara, P
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1518 (03): : 237 - 248
  • [10] Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma
    Cao, Zhuoxiao
    Yang, Cuiqing
    Wang, Yifang
    Wang, Chao
    Wang, Qingyang
    Ye, Gang
    Liu, Tingting
    Wang, Qin
    Wang, Huanyu
    Gong, Yanxue
    Wang, Biye
    Jiang, Fuwei
    BLOOD, 2022, 140 : 7378 - 7378
12345